Cary, NC

Magnolia Clinical Research, LLC.

Depressive Disorder

Major Depressive Disorder

Depression

SP-624

Sirtsei Pharmaceuticals

condition

allSponsorName

Rho, Inc.

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a Phase 2B clinical study evaluating the effectiveness and safety of SP-624 as compared to placebo in the treatment of adults with Major Depressive Disorder.

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Magnolia Clinical Research, LLC. | Cary, NC

Site insights

Work at this site?

Active trials

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

Trial sponsors